Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Elizabeth Atkins

Research Assistant

United Kingdom

Jump to: Affiliations Teaching Research Publications

Affiliations
Department of Infection Biology
Faculty of Infectious and Tropical Diseases

Teaching

2025: Distance Learning Tutor on IDM201 Bacterial Infections

2024: Supervision of 8-week undergraduate research project

2019 - 2021: Distance Learning Tutor on IDM204 Viral Infections
2018 - 2022: Exam marking for Medical Microbiology.

Research

Development of new vaccines for respiratory and meningococcal bacterial disease. Development of new technology for the manufacturing of glycoconjugate vaccines.

Research Area
Bacteria
Immunisation
Vaccines
Bacteriology
Vaccinology
Disease and Health Conditions
Infectious diseases
Respiratory diseases
Country
United Kingdom

Selected Publications
The stability of secreted, acid-labile H77/JFH-1 hepatitis C virus (HCV) particles is altered by patient isolate genotype 1a p7 sequences.
ATKINS, E; Tatineni, R; Li, H; Gretch, D; Harris, M; Griffin, S;
2013
Virology
Recent Advances in Bioconjugate Vaccine Development.
WREN, BW; Hall, CL; TERRA, VS; HARRISON, MA; ATKINS, E; NASHER, F; PASSMORE, IJ;
2025
Vaccines
Modular Combinatorial DNA Assembly of Group B Streptococcus Capsular Polysaccharide Biosynthesis Pathways to Expediate the Production of Novel Glycoconjugate Vaccines.
HARRISON, MA; ATKINS, E; Faulds-Pain, A; Heap, JT; WREN, BW; PASSMORE, IJ;
2025
Vaccines
Investigation into the efficiency of diverse N-linking oligosaccharyltransferases for glycoengineering using a standardised cell-free assay.
Lehri, B; ATKINS, E; SCOTT, TA; ABOUELHADID, S; WREN, BW; CUCCUI, J;
2024
Microbial biotechnology
Development of a novel glycoengineering platform for the rapid production of conjugate vaccines.
ABOUELHADID, S; ATKINS, ER; Kay, EJ; PASSMORE, IJ; North, SJ; Lehri, B; Hitchen, P; Bakke, E; Rahman, M; Bossé, JT; Li, Y; TERRA, VS; Langford, PR; Dell, A; WREN, BW; CUCCUI, J;
2023
Microbial cell factories
Use of Precision-Cut Tissue Slices as a Translational Model to Study Host-Pathogen Interaction.
Majorova, D; ATKINS, E; Martineau, H; Vokral, I; Oosterhuis, D; Olinga, P; WREN, B; CUCCUI, J; Werling, D;
2021
Frontiers in veterinary science
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza.
Scott, C; Kankanala, J; Foster, TL; Goldhill, DH; Bao, P; Simmons, K; Pingen, M; Bentham, M; ATKINS, E; Loundras, E; Elderfield, R; Claridge, JK; Thompson, J; Stilwell, PR; Tathineni, R; McKimmie, CS; Targett-Adams, P; Schnell, JR; Cook, GP; Evans, S; Barclay, WS; Foster, R; Griffin, S;
2020
PLOS PATHOGENS
Genetic and functional heterogeneity of the hepatitis C virus p7 ion channel during natural chronic infection.
Li, H; ATKINS, E; Bruckner, J; McArdle, S; Qiu, WC; Thomassen, LV; Scott, J; Shuhart, MC; Livingston, S; Townshend-Bulson, L; McMahon, BJ; Harris, M; Griffin, S; Gretch, DR;
2011
Virology
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
Foster, TL; Verow, M; Wozniak, AL; Bentham, MJ; Thompson, J; ATKINS, E; Weinman, SA; Fishwick, C; Foster, R; Harris, M; Griffin, S;
2011
Hepatology (Baltimore, Md.)
Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability.
Carter, SD; Dent, KC; ATKINS, E; Foster, TL; Verow, M; Gorny, P; Harris, M; Hiscox, JA; Ranson, NA; Griffin, S; Barr, JN;
2010
FEBS letters
See more information

Contact

United Kingdom